Skip to main content

PHOTOS: Artemis II returns to Earth with a Pacific Ocean splashdown

Artemis II’s astronauts closed out humanity’s first lunar voyage in more than half a century with a Pacific splashdown on Friday, blazing records near the moon with grace and joy.

It was a dramatic grand finale to a 10-day mission that revealed not only swaths of the lunar far side never seen before by human eyes, but a total solar eclipse and a parade of planets, most notably our own shimmering Earth against the endless black void of space.

With their flight now complete, the four astronauts have set NASA up for a moon landing by another crew in just two years and a full-blown moon base within the decade.

The triumphant moon-farers — commander Reid Wiseman, pilot Victor Glover, Christina Koch and Canada’s Jeremy Hansen — emerged from their bobbing capsule into the sunlight off the coast of San Diego.

Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue

SANTIAGO, Chile (AP) — When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic. It was a hantavirus, one of a family of viruses that have been known for decades and are thought to exist around the world. Teams of researchers, including in Chile, Argentina and the United States, have long been trying to find and develop drugs and vaccines. But because the viruses are relatively rare and don't spread easily between people, there hasn't been enough sustained investment by governments, global health groups, or drug companies to pay for the extensive safety and efficacy testing needed to make them available. Still, there have been some promising developments. Researchers on Wednesday published a hint that a drug used for an autoimmune disease may help hantavirus patients fight off the most deadly symptoms.
Read Next Story